MDM2 COMBINATION THERAPY INCLUDING AN MDM2 INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS

摘要

The present invention provides a combination therapy comprising an MDM2 inhibitor and one or more additional pharmaceutically active agents, particularly for the treatment of cancer. The present invention also relates to a pharmaceutical composition comprising an MDM2 inhibitor and at least one further pharmaceutically active agent for the treatment of cancer.